$ESSA Pharma(EPIX.US)$Director BERGER FRANKLIN M purchased 23,259 shares of Common Stocks on Nov 21, 2023 at an average price of $5.73 for a total value of $133.27K.
$ESSA Pharma(EPIX.US)$I dont put a lot of faith in analysts ratings. Especially some, seems like sometimes these analysts just pull numbers from their As*? hehehe! But ive seen more than one ticker take off on analysts updates higher! And well this ticker had some good PR lately and more to come. Here is the latest analysts update! (. The word on The Street in general, suggests a Strong Buy analyst consensus rating for ESSA Pharma with a $18.33 average price target, implying a 356.54% up...
$ESSA Pharma(EPIX.US)$ESSA Pharma Presents Updated Phase 1 Masofaniten (EPI-7386) Clinical Data at the 30th Annual Prostate Cancer Foundation Scientific Retreat PR Newswire· Combination of masofaniten plus enzalutamide continues to be well tolerated with deep and durable reductions in PSA in patients with mCRPC Across all cohorts of patients including those recently enrolled into cohort four, 81% of patients achieved PSA90, 69% of patients achieved PSA90 in less than 90 days, and 56% of pa...
Implied volatility is a measure of the market's expectation of the potential price movements of the stock in the future. Here are the stocks with the most notable implied volatility today. $ESSA Pharma(EPIX.US)$saw its stock rise by 22.60% during the previous trading session. This surge in price was accompanied by a notable increase in option volume, which totaled 3.40K. The option market for ESSA Pharma is currently displaying a high l...
ESSA Pharma股票討論區
PR Newswire·
Combination of masofaniten plus enzalutamide continues to be well tolerated with deep and durable reductions in PSA in patients with mCRPC
Across all cohorts of patients including those recently enrolled into cohort four, 81% of patients achieved PSA90, 69% of patients achieved PSA90 in less than 90 days, and 56% of pa...
$ESSA Pharma(EPIX.US)$ saw its stock rise by 22.60% during the previous trading session. This surge in price was accompanied by a notable increase in option volume, which totaled 3.40K. The option market for ESSA Pharma is currently displaying a high l...
暫無評論